IndraLab

Statements

Regorafenib inhibits JUN. 1 / 1

| 1

reach

"Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS and MAPK, PI3K/Akt/mTOR and Fos and Jun pathways."

32457362

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Regorafenib inhibits JUN. 1 / 1

INDRA sources:

Databases

Reading